Aligns with National Quality/Patient Safety Initiatives; Geared to Reducing
Medication Errors, Enhancing Operating Room Efficiencies
LAKE FOREST, Ill., Dec. 3 /PRNewswire/ -- PharMEDium Services, LLC, the leading provider of outsourced hospital compounded sterile preparations, is offering availability of compounded pre-filled, perioperative anesthesia drugs, an effort devoted to reducing medication errors and improving OR efficiencies. The service line covers the most commonly used drugs in the OR, including about 75 percent of those typically used in surgical procedures, said Rich Kruzynski, R.Ph., PharMEDium President.
(http://www.newscom.com/cgi-bin/prnh/20051202/PHARMEDIUMLOGO )
"The major features of this new service offering -- enhanced labeling, color coding consistent with physician practice, and dual banding of the drug name -- are designed with quality, patient safety, and efficiency as the paramount factors," Kruzynski said. "The pre-filled OR anesthesia preparations may improve the ability of anesthesiologists, nurse anesthetists, and pharmacists in the perioperative setting to provide optimal patient care and reduce the potential for medication errors."
Compounded ready-to-use preparations address a host of OR risk factors -- such as "look-alike" vials, syringes, and high-risk medications that lack labels and bar codes -- that can contribute to medication errors, Kruzynski said.
For example, the service line uses labels for Anesthesiology conforming to standards of the American Society for Testing and Materials (ASTM). To enhance drug recognition, PharMEDium color-codes syringe preparations by class (orange for sedatives, red for neuromuscular blocking agents {NMBs}, blue for narcotics, etc.) consistent with these standards. Drug names are color-coded and dual-banded (so physicians can see the drug name on a syringe from any angle), and shapes on labels assist in distinguishing concentrations of drugs within families. Labels clearly show an RSS composite bar code, including NDC number, lot, and expiration date, so hospitals can better track and reconcile high-risk drugs, enhance inventory control, and reduce unused or wasted drug admixtures.
Pre-filled perioperative compounded drugs can free up critical minutes for anesthesiologists and other OR clinicians to attend to patient needs and ensure the highest quality, Kruzynski said. "Proper administration of antibiotics and beta blockers is critical to improving surgical outcomes and reducing surgical complications. This initiative is a helpful step toward that end," he said.
About PharMEDium Services, LLC
For more than 15 years, PharMEDium has been the leading provider of outsourced compounding services. In that time, PharMEDium has grown into a nationwide network of state licensed and federally registered compounding centers providing trusted solutions to more than 1,800 hospitals throughout the United States. Managed by licensed pharmacists and staffed by certified technicians, the company complies with all applicable state laws and FDA regulations, including USP Chapter < 797 >, as well as DEA and cGMP requirements.
'/>"/>
| SOURCE PharMEDium Services, LLC Copyright©2007 PR Newswire. All rights reserved |
Related medicine news :
1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |